Details for Patent: 8,907,099

« Back to Dashboard

Which drugs does patent 8,907,099 protect, and when does it expire?

Patent 8,907,099 protects ONGENTYS and is included in one NDA.

This patent has forty-two patent family members in twenty-seven countries.

Summary for Patent: 8,907,099

Title:	Nitrocatechol derivatives as COMT inhibitors
Abstract:	New compounds of formula I are described. The compounds have potentially valuable pharmaceutical properties in the treatment of some central and peripheral nervous system disorders.
Inventor(s):	David Alexander Learmonth, Laszlo Erno Kiss, Pedro Nuno Leal Palma, Humberto Dos Santos Ferreira, Patricio Manuel Vieira Araújo Soares Da Silva
Assignee:	Bial Portela and Cia SA
Application Number:	US13/442,356
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 8,907,099

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Amneal	ONGENTYS	opicapone	CAPSULE;ORAL	212489-001	Apr 24, 2020		RX	Yes	No	8,907,099			Y
Amneal	ONGENTYS	opicapone	CAPSULE;ORAL	212489-002	Apr 24, 2020		RX	Yes	Yes	8,907,099			Y

Foreign Priority and PCT Information for Patent: 8,907,099

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0515327.5	Jul 26, 2005
	06008203	Apr 20, 2006
	06011073	May 30, 2006

International Family Members for US Patent 8,907,099

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1907382		300848	Netherlands
European Patent Office	1907382		122016000095	Germany
European Patent Office	1907382		PA2016036	Lithuania
European Patent Office	1907382		CA 2016 00061	Denmark
European Patent Office	1907382		93327	Luxembourg